Search Within

Taha Merghoub

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (24)
  2. Melanoma and Immunotherapeutics Service (24)
  3. Population Sciences Research Program (24)
  4. Solid Tumor Oncology Division (24)
  5. GSK Faculty (23)
  6. Biostatistics Service (21)

More Groups

People
  1. Jedd Wolchok (19)
  2. Katherine Panageas (18)
  3. Sadna Budhu (10)
  4. Cailian Liu (9)
  5. Hong Zhong (8)
  6. Daniel Hirschhorn Cymerman (7)

More People

Years
  1. 2022 (3)
  2. 2021 (4)
  3. 2020 (2)
  4. 2019 (2)
  5. 2018 (6)
  6. 2017 (3)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (3)
  2. Cancer Cell (2)
  3. Journal of Clinical Investigation (2)
  4. Journal of Clinical Oncology (2)
  5. Blood (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (3)
  3. Biomed Central Ltd (3)
  4. American Association for the Advancement of Science (2)
  5. American Society for Clinical Investigation (2)
  6. Cell Press (2)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Massively parallel sequencing analysis of benign melanocytic naevi
    Journal Article

    Lozada, J. R.; Geyer, F. C.; Selenica, P.; Brown, D.; Alemar, B.; Merghoub, T.; Berger, M. F.; Busam, K. J.; Halpern, A. C.; Weigelt, B.; more...
    Histopathology (2019)

    Fulltext@MSK | Save
  • Modulation of T(FH)-like cells and anti-tumor activity of immune checkpoint blockade
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Adipocyte-derived lipids mediate melanoma progression via FATP proteins
    Journal Article

    Zhang, M.; Di Martino, J. S.; Bowman, R. L.; Campbell, N. R.; Baksh, S. C.; Simon-Vermot, T.; Kim, I. S.; Haldeman, P.; Mondal, C.; Yong-Gonzales, V.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Blockade of surface-bound TGF-ß on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
    Journal Article

    Budhu, S.; Schaer, D. A.; Li, Y.; Toledo-Crow, R.; Panageas, K.; Yang, X.; Zhong, H.; Houghton, A. N.; Silverstein, S. C.; Merghoub, T.; more...
    Science Signaling (2017)

    Fulltext@MSK | Save